LLY
Eli Lilly and Company
LLY has the edge over NET overall, supported by stronger fundamentals and lower modeled downside.
NET
Cloudflare, Inc.
NET's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
NET Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Unavailable |
NET's revenue and cash flow are currently strong, but its profitability is weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
NET PE Valuation
NET has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
NET Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for NET, with profitability improving. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over NET on earnings quality, reporting a profit while its opponent remains loss making.
NET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.75 | — |
| Q3 2026 | -$0.68 | -$0.37 |
| Q2 2026 | -$0.58 | -$0.23 |
| Q1 2026 | -$0.25 | -$0.01 |
| Q4 2025 | -$0.29 | -$0.06 |
| Q3 2025 | -$0.31 | -$0.05 |
| Q2 2025 | -$0.35 | -$0.06 |
| Q1 2025 | -$0.24 | +$0.29 |
| Q4 2024 | -$0.23 | +$0.32 |
NET is still losing money, but less than at its worst: $0.68 per share over the past year, against $0.91 at its worst in mid-2022.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over NET on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over NET on profitability, with a higher operating margin.
NET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $782.5M | +39% |
| Q2 2026 | $696.1M | +36% |
| Q1 2026 | $639.8M | +34% |
| Q4 2025 | $614.5M | +34% |
| Q3 2025 | $562M | +31% |
| Q2 2025 | $512.3M | +28% |
| Q1 2025 | $479.1M | +27% |
| Q4 2024 | $459.9M | +27% |
NET's revenue has grown year over year every quarter since late 2020: $783M last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.7% | -2 points |
| Q2 2026 | -30% | -16 points |
| Q1 2026 | -9.7% | +1.4 points |
| Q4 2025 | -8% | -0.5 points |
| Q3 2025 | -6.7% | +0.5 points |
| Q2 2025 | -13% | -4.5 points |
| Q1 2025 | -11% | +3.3 points |
| Q4 2024 | -7.5% | +4.3 points |
NET's operating margin was −8.7% last quarter, down 2 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
NET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $93.6M | +13% |
| Q2 2026 | $67.6M | +69% |
| Q1 2026 | $93.1M | +55% |
| Q4 2025 | $105.2M | +94% |
| Q3 2025 | $82.5M | +51% |
| Q2 2025 | $39.9M | -12% |
| Q1 2025 | $59.9M | +44% |
| Q4 2024 | $54.2M | -0.9% |
NET generated $359M in free cash flow over the past year, up 52% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
NET Net Leverage
NET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
NET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 37.6 | Neutral |
NET's weekly RSI is 56 (neutral) and its Stochastic is 38 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
NET PE vs Technology Sector
NET has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over NET on trend strength, trading above more of its moving averages.
NET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $318.6 | 0% below |
| 20 week MA | $299.8 | 6.2% above |
| 50 week MA | $241.0 | 32% above |
| 100 week MA | $204.9 | 55% above |
| 200 week MA | $139.8 | 128% above |
NET's trend is up, with a small recent dip: it's below only its 8-week average, and 128% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
NET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $85.0 | +409% |
| 2021 | $85.0 | $137.3 | +62% |
| 2022 | $137.3 | $43.8 | -68% |
| 2023 | $43.8 | $83.3 | +90% |
| 2024 | $83.3 | $110.6 | +33% |
| 2025 | $110.6 | $202.4 | +83% |
| 2026 YTD | $202.4 | $318.5 | +57% |
NET has the edge over LLY on returns for 2026, with the stronger performance.